'Someone should oversee it': patient perspectives on the ethical issues arising with the regulation of probiotics

scientific article

'Someone should oversee it': patient perspectives on the ethical issues arising with the regulation of probiotics is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/HEX.12027
P932PMC publication ID4022694
P698PubMed publication ID23279082

P50authorRichard R SharpQ87149211
Gail GellerQ58609081
Krista L HarrisonQ59159923
P2093author name stringJennifer B McCormick
MaryBeth Mercer
Patricia Marshall
Ruth M Farrell
Gail Geller
Jon Tilburt
Margaret A Brinich
Janelle Highland
P2860cites workWho does the public trust? The case of genetically modified food in the United StatesQ81503200
Position of the American Dietetic Association: functional foodsQ83594408
Probiotics for the prevention of pediatric antibiotic-associated diarrheaQ24235039
Intestinal microbiota in human health and disease: the impact of probioticsQ24628739
The NIH Human Microbiome ProjectQ24642619
The human microbiome projectQ29547661
Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention.Q33450486
Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel diseaseQ34191499
Gut microbiome-host interactions in health and diseaseQ34971430
How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndromeQ35457152
Public Attitudes and Beliefs About GeneticsQ37778383
Clinical utility of probiotics in inflammatory bowel diseaseQ37880028
Human gut microbiota and its relationship to health and diseaseQ37897638
Probiotics in the treatment of human inflammatory bowel diseases: update 2011.Q37944981
Human health and disease in a microbial worldQ38464425
Creating public alienation: expert cultures of risk and ethics on GMOsQ47615412
Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugsQ80463718
P433issue2
P921main subjectmedical ethicsQ237151
research ethicsQ1132684
probioticsQ1816730
P304page(s)250-261
P577publication date2012-12-28
P1433published inHealth ExpectationsQ15753949
P1476title'Someone should oversee it': patient perspectives on the ethical issues arising with the regulation of probiotics
P478volume18

Reverse relations

cites work (P2860)
Q54969645Help, hope and hype: ethical considerations of human microbiome research and applications.
Q34320244Maternal perspectives on the use of probiotics in infants: a cross-sectional survey.
Q42040216Randomised controlled trial of Lactobacillus rhamnosus (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol
Q58659933The Human Microbiome and Public Health: Social and Ethical Considerations

Search more.